Opexa Pharmaceuticals, Inc.
1709 Dryden Road
Suite 911
Houston
Texas
77030
United States
Tel: 713-791-9538
Fax: 713-795-4602
Website: http://www.opexapharmaceuticals.com/
12 articles about Opexa Pharmaceuticals, Inc.
-
Opexa Pharmaceuticals, Inc. Strengthens Patent Portfolio With Expansion Into B-Cell Diseases And Announces Allowance Of 98th T-Cell Patent
9/29/2014
-
Opexa Pharmaceuticals, Inc. Announces News Release And Conference Call Schedule To Discuss Second Quarter 2014 Financial Results
8/11/2014
-
Opexa Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 15th Annual Global Investment Conference
9/5/2013
-
Opexa Pharmaceuticals, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference
12/9/2011
-
Opexa Pharmaceuticals, Inc. Executes Strategic Service Agreement with the American Red Cross
5/17/2011
-
Opexa Pharmaceuticals, Inc. to Participate in Panel Discussion on Personalized Medicine for Multiple Sclerosis
4/1/2010
-
Seasoned Clinical Development Expert Joins Opexa Pharmaceuticals, Inc. to Lead Tovaxin(R) Development in Multiple Sclerosis
12/2/2009
-
Opexa Pharmaceuticals, Inc. Regains NASDAQ Compliance Following Stem Cell Agreement
8/10/2009
-
Opexa Pharmaceuticals, Inc. Reports First Quarter 2008 Financial Results and Updates on Tovaxin(R) Phase IIb Study
5/14/2008
-
Opexa Pharmaceuticals, Inc. Presents Tovaxin Phase I/II Data at the American Academy of Neurology 60th Annual Meeting
4/16/2008
-
The Day In Review: Cell Genesys, Inc. Climbs On GVAX Results
4/4/2007
-
PharmaFrontiers Changes Name To Opexa Pharmaceuticals, Inc.
6/19/2006